NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

NBER Publications by Patricia M. Danzon

Contact and additional information for this authorAll NBER papers and publicationsNBER Working Papers onlyInformation about this author at RePEc

Working Papers and Chapters

January 2013Regulation of the Pharmaceutical-Biotechnology Industry
with Eric L. Keuffel
in Economic Regulation and Its Reform: What Have We Learned?, Nancy L. Rose, editor
December 2012Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context
with Adrian K. Towse, Jorge Mestre-Ferrandiz: w18593
July 2011Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets
with Michael F. Furukawa: w17226
Vaccine Supply: Effects Of Regulation And Competition
with Nuno S. Pereira: w17205

Published: Patricia Danzon & Nuno Sousa Pereira, 2011. "Vaccine Supply: Effects of Regulation and Competition," International Journal of the Economics of Business, Taylor and Francis Journals, vol. 18(2), pages 239-271. citation courtesy of

June 2011Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement
with Andrew W. Mulcahy, Adrian K. Towse: w17174

Published: “Pharmaceutical pricing in emerging markets: Effects of income, competition, and procurement” with Andrew W. Mulcahy and Adrian K. Towse. Health Economics 2013. DOI: 10.1002/hec.3013

May 2008Effects of Regulation on Drug Launch and Pricing in Interdependent Markets
with Andrew J. Epstein: w14041
July 2004Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand
with Jonathan D. Ketcham
in Frontiers in Health Policy Research, Volume 7, David M. Cutler and Alan M. Garber, editors
June 2004Mergers and Acquisitions in the Pharmaceutical and Biotech Industries
with Andrew Epstein, Sean Nicholson: w10536

Published: Patricia M. Danzon & Andrew Epstein & Sean Nicholson, 2007. "Mergers and acquisitions in the pharmaceutical and biotech industries," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 307-328. citation courtesy of

October 2003Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand
with Jonathan D. Ketcham: w10007

Published:

July 2003The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s
with Y. Richard Wang, Liang Wang: w9874

Published: Patricia M. Danzon & Y. Richard Wang & Liang Wang, 2005. "The impact of price regulation on the launch delay of new drugs-evidence from twenty-five major markets in the 1990s," Health Economics, John Wiley & Sons, Ltd., vol. 14(3), pages 269-292. citation courtesy of

April 2003Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances
with Sean Nicholson, Nuno Sousa Pereira: w9615

Published: Danzon, Patricia M., Sean Nicholson and Nuno Sousa Pereira. "Productivity In Pharmaceutical-Biotechnology R&D: The Role Of Experience And Alliances," Journal of Health Economics, 2005, v24(2,Mar), 317-339. citation courtesy of

June 2002Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality
with Sean Nicholson, Jeffrey S. McCullough: w9007

Published: Sean Nicholson, 2005. "Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality," Journal of Business, University of Chicago Press, vol. 78(4), pages 1433-1464, July. citation courtesy of

January 1999The Effects of Price Regulation on Productivity in Pharmaceuticals
with Allison Percy
in International and Interarea Comparisons of Income, Output, and Prices, Alan Heston and Robert E. Lipsey, editors

Contact and additional information for this authorAll NBER papers and publicationsNBER Working Papers onlyInformation about this author at RePEc

 
Publications
Activities
Meetings
NBER Videos
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us